Roth Capital Has Weak Forecast for REVB FY2028 Earnings
Revelation Biosciences, Inc. (NASDAQ:REVB – Free Report) – Analysts at Roth Capital reduced their FY2028 earnings estimates for Revelation Biosciences in a research note issued to investors on Thursday, June 5th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of $0.84 per share for the year, down from their previous […]
Revelation Biosciences, Inc. (NASDAQ:REVB – Free Report) – Analysts at Roth Capital reduced their FY2028 earnings estimates for Revelation Biosciences in a research note issued to investors on Thursday, June 5th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of $0.84 per share for the year, down from their previous […]
